DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Barnet Dulaney Perkins Eye Centers

Status: Enrolling

Conditions: Open Angle Glaucoma (OAG)

Treatments: Device: DSLT enables newly diagnosed patients to remain well controlled and off medications

Study type: Observational

Funder types: NETWORK; Industry

Identifiers

NCT06933836

Alcon - IIT Proposal 95645649

Details and patient eligibility

About

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Full description

DSLT enables newly diagnosed patients to remain well controlled and off medications

Enrollment: 55 estimated patients

Sex: All

Ages: 30+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary open angle glaucoma
• Patients age 30 or greater with an IOP of 18-26 mmHg
• Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
• DSLT procedure

Exclusion criteria

• History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
• Angle closure patients
• Ocular Hypertension
• Baseline VF MD of worse than -12dB
• Uncontrolled systemic microvascular disease (eg. HTN, DM)
• Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Trial design

55 participants in 1 patient group

Treatment naïve (including medication in either eye, previous laser or surgery) mild to moderate POA

Description:

(including medication in either eye, previous laser or surgery) mild to moderate POA

Treatment:

Device: DSLT enables newly diagnosed patients to remain well controlled and off medications